Company Number: 13554709

Analysis Date: 2025-07-19 12:45 UTC

1. Risk Rating: LOW
   The company exhibits strong solvency and liquidity metrics consistent with a micro-entity in the medical practice sector. It has a healthy net asset position and substantial positive working capital, with no indications of overdue filings or insolvency proceedings.

2. Key Concerns:

• Limited Scale: As a micro-entity with only one employee, operational resilience and growth potential may be limited.
• Single Director and PSC: Control concentrated in one individual (Dr. Hira Azim) may pose governance risks, including succession or continuity concerns.
• No Audit or External Assurance: Reliance on unaudited accounts means financial data has not been independently verified, which could mask underlying issues.

3. Positive Indicators:

• Strong Liquidity: Current assets significantly exceed current liabilities (£108,857 vs £11,026 in 2024), indicating robust short-term financial health.
• Growing Net Assets: Net assets increased from £13,453 in 2021 to £98,787 in 2024, reflecting positive retained earnings or capital injection.
• Compliance: Accounts and confirmation statements are filed on time with no overdue filings, demonstrating good regulatory compliance.
• Clear Ownership and Control: PSC and director information is transparent and consistent.

4. Due Diligence Notes:

• Review detailed profit and loss data (not provided) to assess revenue sustainability and profitability trends.
• Confirm nature and collectability of current assets (likely cash and receivables) to validate liquidity strength.
• Investigate any contingent liabilities or off-balance sheet obligations not disclosed in micro-entity accounts.
• Assess dependency on the sole director for operations and management continuity.
• Verify that the company’s exemption from audit is appropriate given its size and complexity.